Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia
Baqsimi (bak-SEE-mee) and Gvoke (JEE-vohk) are new glucagon Rxs that will be game changers for treating severe hypoglycemia.
Baqsimi is INTRANASAL glucagon. It's a ready-to-use powder sprayed in one nostril...and is absorbed without inhaling.
Gvoke is a SUBCUTANEOUS injection. It's already mixed and drawn up in a prefilled syringe. An auto-injector will be available next year.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote